Neuromyotonia (Q41389): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: G71.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:32, 13 August 2026
Neuromyotonia or Isaac's syndrome is an immune-mediated peripheral nerve disorder characterised by continuous muscle fibre activity at rest resulting in muscle stiffness, cramps, myokymia, and pseudomyotonia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 8C71.4 |
||
| English | Neuromyotonia |
Neuromyotonia or Isaac's syndrome is an immune-mediated peripheral nerve disorder characterised by continuous muscle fibre activity at rest resulting in muscle stiffness, cramps, myokymia, and pseudomyotonia. |
Statements
CID11:8C71.4
0 references
dki-india-8C71.4
0 references
Concluído
0 references
13 August 2026
0 references
